Talaris Therapeutics Inc
TALS
Get informed when a big investor buys or sells
+ FollowMarket Cap$116.44M
Close$
Share Statistics
| Market cap | $116.44 Million |
|---|---|
| Enterprise Value | $85.17 Million |
| Dividend Yield | $1.51 (-) |
| Earnings per Share | $-2.89 |
| Beta | 2.18 |
| Outstanding Shares | 25,755,000 |
Return
| Return on Equity | -37.34% |
|---|---|
| Return on Assets | -35.94% |
| Return on Invested Capital | -43.95% |
Valuation & Multiples
| P/E Ratio | -18.09 |
|---|---|
| PEG | -56.45 |
| Price to Sales | - |
| Price to Book Ratio | 0.27 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.75 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Talaris Therapeutics Inc
82 employees